JOSE PABLO
MIRAMONTES GONZALEZ
PROFESOR CONTRATADO DOCTOR
Universidad de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Salamanca (15)
2023
-
Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality
Precision Cancer Medicine
-
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
Cancers, Vol. 15, Núm. 17
-
Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial
European Journal of Clinical Investigation, Vol. 53, Núm. 1
-
Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Chinese Clinical Oncology, Vol. 12, Núm. 6
-
Estimands: a new way of interpreting the results of clinical essays
Spanish Journal of Medicine, Vol. 3, Núm. 1
-
Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»
Revista Espanola de Geriatria y Gerontologia
2022
-
Cancer and elderly: Two incompatible concepts for intensive care?
Revista Espanola de Geriatria y Gerontologia
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
2021
-
Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications
Biomolecules, Vol. 11, Núm. 2, pp. 1-16
-
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
Life, Vol. 11, Núm. 12
-
Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies
Journal of Clinical Medicine, Vol. 10, Núm. 9
2020
-
VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension
European Journal of Internal Medicine, Vol. 80, pp. 60-65
2019
-
Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months
Diabetes Research and Clinical Practice, Vol. 158
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22